TW200504054A - Heteroarylsulfonanilide derivative and pharmaceutical composition containing the same - Google Patents

Heteroarylsulfonanilide derivative and pharmaceutical composition containing the same

Info

Publication number
TW200504054A
TW200504054A TW093109855A TW93109855A TW200504054A TW 200504054 A TW200504054 A TW 200504054A TW 093109855 A TW093109855 A TW 093109855A TW 93109855 A TW93109855 A TW 93109855A TW 200504054 A TW200504054 A TW 200504054A
Authority
TW
Taiwan
Prior art keywords
optionally substituted
heteroarylsulfonanilide
derivative
same
lower alkyl
Prior art date
Application number
TW093109855A
Other languages
English (en)
Inventor
Hiroshi Harada
Masaaki Sawa
Kazuhiro Mizuno
Hirotaka Tateishi
Shiro Kato
Mayumi Oue
Hiroshi Tsujiuchi
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of TW200504054A publication Critical patent/TW200504054A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/06—Peri-condensed systems
TW093109855A 2003-04-10 2004-04-09 Heteroarylsulfonanilide derivative and pharmaceutical composition containing the same TW200504054A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003106051 2003-04-10

Publications (1)

Publication Number Publication Date
TW200504054A true TW200504054A (en) 2005-02-01

Family

ID=33156899

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093109855A TW200504054A (en) 2003-04-10 2004-04-09 Heteroarylsulfonanilide derivative and pharmaceutical composition containing the same

Country Status (2)

Country Link
TW (1) TW200504054A (zh)
WO (1) WO2004089936A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102171191A (zh) * 2008-10-09 2011-08-31 旭化成制药株式会社 吲唑衍生物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1070477C (zh) * 1994-11-29 2001-09-05 大日本制药株式会社 吲哚衍生物
JP2001316292A (ja) * 1999-09-03 2001-11-13 Takeda Chem Ind Ltd 医 薬
JPWO2003106418A1 (ja) * 2002-06-12 2005-10-13 住友製薬株式会社 インドール、インダゾール、およびベンズアゾール類

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102171191A (zh) * 2008-10-09 2011-08-31 旭化成制药株式会社 吲唑衍生物

Also Published As

Publication number Publication date
WO2004089936A1 (ja) 2004-10-21

Similar Documents

Publication Publication Date Title
HK1077822A1 (en) Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
MY141559A (en) Triazole derivatives as tachykinin receptor antagonists
AU8345491A (en) Heterocyclic derivatives
ES2161373T3 (es) Derivados de meta-guanidina, urea, tiourea o acido azaciclico-aminobenzoico como antagonistas de integrinas.
WO2003084938A3 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
WO2008002596A3 (en) Adenosine a2a receptor antagonists
WO2005042516A3 (en) Ligands of melanocortin receptors and compositions and methods related thereto
MXPA02004448A (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
AU4491301A (en) Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
BRPI0207102A8 (pt) forma cristalina, composição farmacêutica, e, uso de uma forma cristalina.
DE60016786D1 (de) Bicyclische vasopressin-agoniste
TW200504054A (en) Heteroarylsulfonanilide derivative and pharmaceutical composition containing the same
IL151488A0 (en) Method for the preparation of citalopram
MXPA04006115A (es) Derivados de imidazoquinolina.
PT1282617E (pt) Derivados de hidantoína com afinidade para os receptores da somatostatina
MY129094A (en) Condensed polycyclic compounds
WO2004078101A3 (en) Urea derivatives having vanilloid receptor antagonist activity
WO2004039808A3 (en) Process for the preparation of ganciclovir
IS2419B (is) Glýsín-setin þíeno[2,3-d]pýrimidín með sameinaða LH og FSH gerandefnisvirkni
MXPA05006587A (es) Compuestos de tiazol como derivados de antagonistas del receptor de la integrina.
GR3029590T3 (en) Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
WO2002062798A3 (en) Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
ATE398131T1 (de) Kondensierte camptothecine als antitumormittel